Skip to content

Study · Not a test of the peptide alone · 2017

1 result

Effect of gonadotropin-inhibitory hormone on luteinizing hormone secretion in humans.

George JT, Hendrikse M, Veldhuis JD, Clarke IJ, Anderson RA, Millar RP

Clinical endocrinology26 Mar 2017Cited by 25 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Kisspeptin-10 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Kisspeptin-10.

  1. 01HumanNot a test of Kisspeptin-10 aloneNon-randomized trialEfficacy outcome

    In healthy men, co-administration of GnIH did not change the LH response to kisspeptin‑10 (60-min LH AUC 6.2 versus 6.3 IU/h).

    In plain wordsIn healthy men, adding GnIH did not change the rise in luteinizing hormone caused by kisspeptin‑10.

    Outcome
    No significant changeKisspeptin-10-stimulated LH response with GnIH
    Study

    n = 4

    Comparator
    Kisspeptin-10 with vehicle
    Outcome group
    Sex hormones and fertility · Endocrine and hormones

    Measurements

    60-min LH AUC
    6.2 IU/h
    kisspeptin-10 alone
    60-min LH AUC
    6.3 IU/h
    kisspeptin-10 with GnIH

    Source sentences

    Summary
    Kisspeptin-10-stimulated LH responses in men were not affected by GnIH co-administration (60-min AUC of LH 6·2 ± 0·8 IU/h with kisspeptin-10 alone, 6·3 ± 1·0 IU/h, kisspeptin-10 with GnIH, P = 0·72).
    1 context sentence
    Summary · context
    Four men were administered kisspeptin-10 (0·3 μg/kg iv bolus) with simultaneous infusion of GnIH (50 μg/kg/h, iv for 3 h) or vehicle.

    In this study, Kisspeptin-10 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Kisspeptin-10.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.